A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiri...

por Boyd, Brooks, Smith, Steven, Gammaitoni, Arnold, Galer, Bradley S., Farfel, Gail M.
Publicado 2019

Heated lidocaine/tetracaine patch for treatment of patellar tendinopathy pain

por Gammaitoni, Arnold R, Goitz, Henry T, Marsh, Stephanie, Marriott, Thomas B, Galer, Bradley S
Publicado 2013

Translation and cultural validation of the University of Washington Caregiver Stress and Benefit Scales

por Amtmann, Dagmar, Bamer, Alyssa M., Salem, Rana, Gammaitoni, Arnold R., Galer, Bradley S., Jensen, Mark P.
Publicado 2021

An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies

por Martin, Parthena, Reeder, Thadd, Sourbron, Jo, de Witte, Peter A. M., Gammaitoni, Arnold R., Galer, Bradley S.
Publicado 2021

Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long‐term open‐label safety extension study

por Lai, Wyman W., Galer, Bradley S., Wong, Pierre C., Farfel, Gail, Pringsheim, Milka, Keane, Martin G., Agarwal, Anupam
Publicado 2020

Fenfluramine significantly reduces day‐to‐day seizure burden by increasing number of seizure‐free days and time between seizures in patients with Dravet syndrome: A time‐to‐event a...

por Sullivan, Joseph, Specchio, Nicola, Devinsky, Orrin, Auvin, Stéphane, Perry, M. Scott, Strzelczyk, Adam, Gil‐Nagel, Antonio, Dai, David, Galer, Bradley S., Gammaitoni, Arnold R.
Publicado 2021

Fenfluramine HCl (Fintepla(®)) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study

por Sullivan, Joseph, Scheffer, Ingrid E., Lagae, Lieven, Nabbout, Rima, Pringsheim, Milka, Talwar, Dinesh, Polster, Tilman, Galer, Bradley, Lock, Michael, Agarwal, Anupam, Gammaitoni, Arnold, Morrison, Glenn, Farfel, Gail
Publicado 2020

Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial

por Nabbout, Rima, Mistry, Arun, Zuberi, Sameer, Villeneuve, Nathalie, Gil-Nagel, Antonio, Sanchez-Carpintero, Rocio, Stephani, Ulrich, Laux, Linda, Wirrell, Elaine, Knupp, Kelly, Chiron, Catherine, Farfel, Gail, Galer, Bradley S., Morrison, Glenn, Lock, Michael, Agarwal, Anupam, Auvin, Stéphane
Publicado 2020

Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study

por Knupp, Kelly G., Scheffer, Ingrid E., Ceulemans, Berten, Sullivan, Joseph, Nickels, Katherine C., Lagae, Lieven, Guerrini, Renzo, Zuberi, Sameer M., Nabbout, Rima, Riney, Kate, Agarwal, Anupam, Lock, Michael, Dai, David, Farfel, Gail M., Galer, Bradley S., Gammaitoni, Arnold R., Polega, Shikha, Davis, Ronald, Gil‐Nagel, Antonio
Publicado 2022

Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial

por Knupp, Kelly G., Scheffer, Ingrid E., Ceulemans, Berten, Sullivan, Joseph E., Nickels, Katherine C., Lagae, Lieven, Guerrini, Renzo, Zuberi, Sameer M., Nabbout, Rima, Riney, Kate, Shore, Svetlana, Agarwal, Anupam, Lock, Michael, Farfel, Gail M., Galer, Bradley S., Gammaitoni, Arnold R., Davis, Ronald, Gil-Nagel, Antonio
Publicado 2022